Earnings season is shifting into high gear as some of America's biggest companies prepare to reveal how demand, spending, and profit margins are holding up. Meanwhile, multibillion-dollar takeovers are keeping dealmakers busy, while fresh cancer-drug breakthroughs and signs of uneven growth in China add to the week's market story.
Check Your 401(k) (Sponsored)
It may be sitting in your 401(k) as a core holding.
Weiss Ratings, whose record through the major financial events of this century is documented in the briefing, just rated this popular stock a “SELL”.
Check whether your 401(k) holds it.
It is not the only one. The briefing names ten popular but vulnerable stocks.
See the ten stocks Weiss rates a SELL.
Get the full Weiss briefing.
Futures at a Glance📈
Futures are rallying to start the week, with tech leading the rebound after last week's AI-driven selloff. Falling oil prices and easing Treasury yields are giving stocks some breathing room, while traders look ahead to major earnings from Meta, Tesla, and Netflix for clues on whether the AI trade can regain its momentum.
Want to make sure you never miss a pre-market alert?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.
Email’s great. Texts are faster.
You’ll be first in line when the market starts moving.
What to Watch
Earnings (Premarket):
· Fifth Third Bancorp [FITB]
Earnings (Aftermarket):
· Steel Dynamics, Inc. [STLD]
· W.R. Berkley Corporation [WRB]
· Crown Holdings, Inc. [CCK]
· AGNC Investment Corp. [AGNC]
· Wintrust Financial Corporation [WTFC]
· Zions Bancorporation N.A. [ZION]
· Western Alliance Bancorporation [WAL]
Earnings (Time Not Supplied):
· Summit Therapeutics Inc. [SMMT]
· Grupo Aeroportuario del Pacífico [PAC]
Economic Reports:
· NAHB Housing Market Index (October): 10:00 am
Market Pulse
U.S. stocks are getting some relief from lower oil prices, with potential Russian sanctions relief easing energy pressures even as Gulf shipping risks linger.
This week's earnings season shifts into high gear as Meta, Tesla, GM, and GE prepare to report, testing expectations for corporate profits, spending, and demand.
AI & Technology
Microsoft reportedly withdrew from Nscale's British data-center project amid concerns about grid connection delays, illustrating how electrical infrastructure limits are complicating the industry's expansion plans.
Anthropic is committing 5% of its equity to a public-benefit fund as the company prepares for an IPO, creating a new mechanism to fund research and mitigate AI-related disruptions.
Healthcare & Biotech
Roche is unveiling Phase 3 results showing its lung cancer drug outperformed rivals, while new breast cancer data strengthen its case for expanding next-generation oncology treatments.
GSK reported a 61% response rate for its experimental small-cell lung cancer treatment, based on an early-stage study that still requires larger trials and longer follow-up.
The Hidden Bill (Sponsored)
The national debt just crossed $40 trillion — about $117,000 for every man, woman and child in America.
Here's the per-person math.
You'll never get an invoice. Washington collects a little at a time, from the buying power of everything you've saved.
Here's how to keep your share off the table.
Foreign buyers of U.S. debt are stepping back and buying something else instead.
Claim your complimentary guide here.
*This is an advertisement. If you no longer wish to receive promotional emails, please unsubscribe here
or write to: 203 Heritage Grove Road, Leander, TX 78641
Finance & Deals
EQT agreed to acquire Australian waste-management group Cleanaway for approximately $6.5 billion including debt, with a substantial premium for shareholders underscoring private equity's appetite for essential infrastructure.
Japan's Daiichi Life offered to acquire the remaining shares of Australian annuity provider Challenger, with a proposed $5.53 billion valuation and a nearly 20% premium.
Capital & Global Economy
China's economy grew 4.5% in the third quarter as exports drove a stronger-than-expected rebound, although sluggish retail sales and a weak property market exposed uneven domestic demand.
Dubai Investments plans to float 20% of DIP Holding, with subscriptions opening later this month as the United Arab Emirates prepares for its first IPO of 2026.
Decimalization -- the switch from fractional stock pricing (like eighths of a dollar) to decimals -- became mandatory on U.S. exchanges in which year?
Movers and Shakers
Disc Medicine (IRON) +32%
Disc Medicine shares surged in premarket trading as the biotech prepared to unveil Phase 3 results for bitopertin, its experimental treatment for a rare blood disorder that causes painful sunlight sensitivity. The company scheduled a webcast for 8 a.m. ET Monday. Positive results could strengthen its path toward FDA approval, making this a pivotal clinical catalyst.
NextNav (NN) +8%
NextNav shares rebounded after Friday's 10% decline, with traders revisiting the company's delayed FCC spectrum approval plans. The regulator recently excluded NextNav's proposed 900 MHz spectrum changes from its October agenda, pushing back a potential catalyst for its GPS-backup technology. Monday's recovery suggests bargain hunting, although regulatory uncertainty remains unresolved.
City Therapeutics (CTY) -6%
City Therapeutics shares retreated in premarket trading following the biotech's A $6.5 Billion Buyout Kicks Off a Big Week for Earnings and Dealmakers. The RNA-focused drug developer raised approximately $200 million in its IPO, pricing shares at $18 before jumping more than 20% during its first session. The pullback suggests some early profit-taking as enthusiasm cools following the initial listing surge.
December Eight Matters (Sponsored)
One analyst believes Elon Musk is preparing to launch the biggest project of his career — and says the key date is December 8.
He claims the clues are already buried in government filings, along with one investment move he believes should be made before December 9.
His full case is laid out in a free masterclass.
See What Elon Filed Before December 8
Everything Else
🚀 The Magnificent Seven reshaped the market but leadership never stays concentrated forever and seven stocks with strong fundamentals and growing influence are already emerging quietly before the headlines catch up.
🏦 Axis Bank fell after disappointing profit results, with higher operating costs and weaker treasury income overshadowing a 37.6% increase in quarterly earnings.
🛢️ Antofagasta ended its Chilean copper strike after 94.5% of participating workers approved a new labor agreement, removing a potential production risk.
💾 CXMT forecast an eightfold revenue surge, benefiting from soaring memory-chip prices, although its shares dropped amid the broader AI selloff.
🖥️ Lasertec fell nearly 5% in Tokyo as concerns about AI infrastructure spending continued to pressure Japanese semiconductor equipment stocks.
⚡ Sumitomo Electric dropped amid renewed tech weakness, losing nearly 5% as investors reduced exposure to AI-related infrastructure and electronics companies.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE ELON INDEX
Our conviction bet on the Musk universe: Tesla, and the companies orbiting his ventures, energy, AI, infrastructure. High-beta by design, for investors who want direct exposure to the trade rather than watching it from the sidelines.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
